HIV and the returning expatriate (Q33669671)

28 July 2017

1 reference

title

HIV and the returning expatriate (English)

1 reference

28 July 2017

Jones ME

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Journal of Travel Medicine

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

99-106

1 reference

Increased mortality among Dutch development workers

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Infections in HIV-infected travelers: risks and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Adult Travelers with HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Transmission of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

21 January 2018

HIV pre-test discussion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Condoms and HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Psoriasis worsened by antimalarial prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

The immunopathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Serial CD4 lymphocyte counts and development of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Primary HIV-1 infection: a new medical emergency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1708-8305.1999.TB00840.X

10.1111/J.1708-8305.1999.TB00840.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference